These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 207959
1. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)]. Mertz DP, Suermann J. Med Klin; 1978 Jun 09; 73(23):867-73. PubMed ID: 207959 [Abstract] [Full Text] [Related]
2. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)]. Mertz DP, Suermann I, Göhmann E. MMW Munch Med Wochenschr; 1978 Aug 25; 120(34):1097-9. PubMed ID: 210375 [Abstract] [Full Text] [Related]
3. [Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)]. Mertz DP, Suermann I, Göhmann E. Med Klin; 1979 Feb 23; 74(8):279-83. PubMed ID: 216895 [Abstract] [Full Text] [Related]
4. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia]. Arntz HR, Klemens UH, Vollmar LJ, Lang PD. Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760 [Abstract] [Full Text] [Related]
5. [Chances in the serum lipid values after conversion to a "reasonable" diet (author's transl)]. Mertz DP, Wobbe HD, Berger A, Göhmann E. Med Klin; 1977 Jan 14; 72(2):47-54. PubMed ID: 189169 [Abstract] [Full Text] [Related]
8. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P, Schwandt P. Klin Wochenschr; 1977 Aug 15; 55(16):791-4. PubMed ID: 198601 [Abstract] [Full Text] [Related]
9. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)]. Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R. Arzneimittelforschung; 1980 Aug 15; 30(11b):2059-62. PubMed ID: 7194060 [Abstract] [Full Text] [Related]
11. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)]. Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R. MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201 [Abstract] [Full Text] [Related]
12. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. Wilson DE, Lees RS. J Clin Invest; 1972 May 20; 51(5):1051-7. PubMed ID: 4341500 [Abstract] [Full Text] [Related]
17. [One year fenofibrate treatment of type II primary hyperlipidaemia. Effects on lipoproteins and biological tolerance (author's transl)]. Drouin P, Méjean L, Lambert D, Wülfert E, Debry G. Nouv Presse Med; 1980 Dec 22; 9(49):3753-7. PubMed ID: 7208342 [Abstract] [Full Text] [Related]
18. Serum lipoprotein lipids after gemfibrozil treatment. Schwandt P, Weisweiler P, Neureuther G. Artery; 1979 Feb 22; 5(2):117-24. PubMed ID: 231950 [Abstract] [Full Text] [Related]